Paul K. Sue, M.D. C.M., is a faculty member in the division of Infectious Diseases in the Department of Pediatrics at UT Southwestern. He is a graduate of the McGill University Faculty of Medicine in Montreal, QC, and completed his internship and residency in pediatrics at the Albert Einstein College of Medicine at Jacobi Medical Center, where he served as chief resident. He completed his fellowship in pediatric infectious diseases at the Johns Hopkins Hospital, where his research focused on the emergence and management of opportunistic infections, particularly hepatitis E virus (HEV) in solid organ transplant recipients. Dr. Sue's clinical interests include the diagnosis and management of opportunistic infections among immunocompromised hosts. Current research interests include the impact of fecal microbiota transplantation on gut microbiota in the setting of Clostridioides difficile infection in children, as well as the effect of gut microbiota modulation in the setting gut colonization with multi-drug resistant organisms. He currently serves as the medical director for the Pediatric Transplant & Immunocompromised Host Infectious Disease service and is co-director of the Fecal Microbiota Transplantation program at Children's Medical Center of Dallas. Dr. Sue is a member of the American Academy of Pediatrics, the Infectious Disease Society of America, the American Academy for the Study of Liver Diseases, and the Pediatric Infectious Disease Society. Most recently Dr. Sue served as a reviewer and facilitator for the Infectious Disease Section at the Pediatric Academic Society meeting in 2015. Dr. Sue was included in D Magazine's Best Doctors list for 2018. He is a previous recipient of the Pediatric Academy Society Resident Research Award, Infectious Disease Society of America Fellow's Travel Grant award, Ruth L. Kirchstein Research Service Award (NIH T32), and the institutional award for excellence in Medical Student teaching at the Jacobi Medical Center.